跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DAPTOMYCIN-DRLA daptomycin 350 mg powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
DAPTOMYCIN-DRLA daptomycin 350 mg powder for injection vial
Approved
STANDARD
DAPTOMYCIN-DRLA daptomycin 350 mg powder for injection vial
Dr Reddys Laboratories Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
95c810331e22037f
Company
Dr Reddys Laboratories Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
95c810331e22037f
Product Name
DAPTOMYCIN-DRLA daptomycin 350 mg powder for injection vial
Artg Id
337788
Artg Name
DAPTOMYCIN-DRLA daptomycin 350 mg powder for injection vial
Sponsor
Dr Reddys Laboratories Australia Pty Ltd
Company Detail Path
/organization/dr-reddys-laboratories-australia-pty-ltd
Artg Date
2021-04-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
95c810331e22037f
Type
Standard
Back to TGA Approvals
